# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-25-007732
Filing Date
2025-02-25
Accepted
2025-02-25 16:19:11
Documents
171
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K FOR THE FISCAL YEAR ENDED DECEMBER 31, 2024 | mrk-20241231.htm iXBRL | 10-K | 5027463
2 | EX-4.11 DESCRIPTION OF SECURITIES | exh411-descriptionofsecuri.htm | EX-4.11 | 261121
3 | EX-10.1 EXECUTIVE INCENTIVE PLAN | exh101-eipplan.htm | EX-10.1 | 52585
4 | EX-10.13 MERCK & CO., INC. U.S. SEPARATION BENEFITS PLAN | exh1013-mrkseparationplan2.htm | EX-10.13 | 1878617
5 | EX-10.31 2024 ANNUAL RSU TERMS & CONDITIONS | exh1031-2024annualrsuterms.htm | EX-10.31 | 377195
6 | EX-10.32 2024 ANNUAL PSU TERMS & CONDITIONS | exh1032-2024annualpsuterms.htm | EX-10.32 | 544084
7 | EX-10.33 2024 ANNUAL NQSO TERMS & CONDITIONS | exh1033-2024annualnqsoterm.htm | EX-10.33 | 186652
8 | EX-10.34 2024 SPECIAL RETENTION RSU TERMS & CONDITIONS | exh1034-2024specialretenti.htm | EX-10.34 | 83970
9 | EX-10.35 OFFER LETTER (LARSON) | exh1035-bettylarsonofferle.htm | EX-10.35 | 64381
10 | EX-10.36 2024 ANNUAL RSU SIGN-ON TERMS & CONDITIONS (LARSON) | exh1036-2024annualrsusignx.htm | EX-10.36 | 87452
11 | EX-19 INSIDER TRADING POLICY | exh19-insidertradingpolicy.htm | EX-19 | 22558
12 | EX-21 SUBSIDIARY LIST | exh21-subsidiarylistasof12.htm | EX-21 | 276395
13 | EX-23 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | exh23-consentofindependent.htm | EX-23 | 2323
14 | EX-24.1 POWER OF ATTORNEY | exh241-powerofattorney.htm | EX-24.1 | 15205
15 | EX-24.2 CERTIFICATION OF BOARD RESOLUTION | exh242-certificationofboar.htm | EX-24.2 | 6759
16 | EX-31.1 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CEO | exh311-rule13ax14a15dx14ac.htm | EX-31.1 | 8068
17 | EX-31.2 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CFO | exh312-rule13ax14a15dx14ac.htm | EX-31.2 | 8103
18 | EX-32.1 SECTION 1350 CERTIFICATION OF CEO | exh321-section1350certific.htm | EX-32.1 | 4057
19 | EX-32.2 SECTION 1350 CERTIFICATION OF CFO | exh322-section1350certific.htm | EX-32.2 | 3662
25 |  | exhibitcover.jpg | GRAPHIC | 348105
26 |  | image_10.jpg | GRAPHIC | 3105
27 |  | image_6.jpg | GRAPHIC | 34787
28 |  | image_8x1.jpg | GRAPHIC | 7990
29 |  | image_9.jpg | GRAPHIC | 6136
30 |  | logo.jpg | GRAPHIC | 6373
31 |  | mrk-20241231_g1.jpg | GRAPHIC | 137767
32 |  | mrk-20241231_g2.jpg | GRAPHIC | 81788
33 |  | mrk-20241231_g3.jpg | GRAPHIC | 28639
34 |  | mrk-20241231_g4.jpg | GRAPHIC | 24577
35 |  | mrk-20241231_g5.jpg | GRAPHIC | 24326
36 |  | mrk-20241231_g6.jpg | GRAPHIC | 26041
37 |  | mrk-20241231_g7.gif | GRAPHIC | 5605
38 |  | mrk-20241231_g8.jpg | GRAPHIC | 31485
39 |  | mrk-20241231_g9.jpg | GRAPHIC | 17845
40 |  | picture1.jpg | GRAPHIC | 4032
| Complete submission text file | 0001628280-25-007732.txt |  | 31592793

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
20 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | mrk-20241231.xsd | EX-101.SCH | 130598
21 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | mrk-20241231_cal.xml | EX-101.CAL | 161739
22 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | mrk-20241231_def.xml | EX-101.DEF | 878153
23 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | mrk-20241231_lab.xml | EX-101.LAB | 1483678
24 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | mrk-20241231_pre.xml | EX-101.PRE | 1216944
174 | EXTRACTED XBRL INSTANCE DOCUMENT | mrk-20241231_htm.xml | XML | 5843465

Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-06571 | Film No.: 25663539
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)